foxo4-dri human trial The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Senolytics: from pharmacological inhibitors to
Description
doi: 10.1016/j.envint.2021.106985 21 GodfreyDIKoayH-FMcCluskeyJGherardinNA
Think of it like this: a doctor needs an X-ray to confirm a broken bone before putting on a cast
People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness leading to death
C.ChanM
